Race Differences Of Cardiac Structure, Function And Mortality In Heart Failure Patients With Preserved Ejection Fraction

Hidemi Sorimachi,Masaru Obokata,Kazunori Omote,Yogesh Reddy,Barry Borlaug

DOI: https://doi.org/10.1016/j.cardfail.2023.10.155

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Background Potential differences in the phenotype of heart failure with preserved ejection fraction (HFpEF) by race or ethnicity has not been assessed in detail. We aimed to characterize racial differences in clinical correlates, cardiac structures, functions, and prognostic importance in HFpEF among Asian, White, and Black populations. Methods and Results A total of 360 Asian, 787 White, and 171 Black patients with HFpEF underwent transthoracic echocardiography were evaluated and followed up for all-cause mortality. The Asian HFpEF group was the oldest and the Black HFpEF group youngest (75±12 vs. 73±13 vs. 62±12 years, p<0.0001) (Figure A). Women constituted the lowest proportion of patients with HFpEF among Asians and but were the highest among Black individuals with HFpEF (49% vs. 56% vs. 73%, p<0.0001) (Figure B). Body mass and obesity prevalence were lower in Asian HFpEF patients and highest in Black HFpEF patients (Figure C). Black individuals with HFpEF had greater LV wall thickening, smaller LV chamber size, and greater LV concentricity (Figure D), with smaller LA volumes (Figure E), but more RV dilatation. Asian individuals with HFpEF had greater LV and LA dilation, and higher LA/LV volume ratio. The Asian HFpEF group had the highest arterial afterload, as assessed by the aortic elastance and systemic vascular resistance indices (Figure F). There were no racial differences in mortality after adjusting for age, sex, and BMI, but multiple cardiac structure/functional changes were differentially associated with increased risk of death. Conclusions Patients with HFpEF of Asian, White, and Black race display differences in age, sex, and body mass, as well as differing changes in cardiac structure and function. While overall survival did not differ, there were distinct relationships between cardiac abnormalities and outcome by race. Consideration of race-related biological differences may be important to individualize risk stratification and potentially treatment strategies in HFpEF.

cardiac & cardiovascular systems